PASS-01 Announcement: A Message from Michelle Capobianco

PASS-01 Announcement: A Message from Michelle Capobianco

Today I am thrilled to announce the launch of our next landmark research investment, PASS-01: a clinical trial that will finally address the diverse nature of this disease and provide personalized treatment options for advanced pancreatic cancer patients....